Hunan Hansen Pharmaceutical Co., Ltd. (SZSE: 002412)
Health Care · Pharmaceuticals · CN
CN¥9.07
-0.33% today · +43.3% 1Y
Hunan Hansen Pharmaceutical Co., Ltd. (SZSE: 002412) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $680.41M and employs 2,108 people.
Over the last twelve months the share price has gained 43.3%, trading between 5.32 and 14.23.
Tweenvest scores Hunan Hansen Pharmaceutical Co., Ltd. across four factors: quality 80/100, value 23/100, growth 51/100, dividend 91/100. Its strongest factor is dividend.
002412 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $680.41M
- Revenue (TTM)
- $148.11M
- P/E
- 19.33
- EPS
- 0.47
- Dividend yield
- 3.31%
- Beta (5Y)
- 0.42
- 52-week high
- CN¥14.23
- 52-week low
- CN¥5.32
- Avg volume (3M)
- —
- Shares outstanding
- 503.20M
- Employees
- 2,108
- Next earnings
- —
About Hunan Hansen Pharmaceutical Co., Ltd.
Hunan Hansen Pharmaceutical Co., Ltd. is engaged in the manufacturing and global distribution of a wide array of both traditional Chinese and Western pharmaceutical products. The company's diverse offerings are available in numerous formats, including injectables, oral liquids, tablets, capsules, granules, syrups, decoctions, tinctures, and pills. Its primary operational base is located in Yiyang, China.
- ISIN
- CNE100000PK2
- Founded
- 1998
- Listed since
- May 25, 2010
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Fuan Pharmaceutical (Group) Co., Ltd.SZSE: 300194 | $689.94M | CN¥3.89 | +1.30% |
| Genomma Lab Internacional, S.A.B. de C.V.BMV: LAB B | $688.75M | MX$12.79 | -0.23% |
| ChengDa Pharmaceuticals Co., Ltd.SZSE: 301201 | $688.50M | CN¥30.49 | +1.13% |
| Wave Life Sciences, Inc.NasdaqGM: WVE | $683.76M | $3.47 | -1.98% |
| Hunan Fangsheng Pharmaceutical Co., Ltd.SHSE: 603998 | $678.15M | CN¥10.36 | +0.68% |
| Sinotherapeutics Inc.SHSE: 688247 | $675.40M | CN¥10.09 | +2.13% |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD.SZSE: 002940 | $671.26M | CN¥22.96 | +0.53% |
| PT Tempo Scan Pacific TbkIDX: TSPC | $665.25M | Rp2,640.00 | -0.38% |
Figures last refreshed Oct 4, 2026.